King Kevin M
Director at IRTC; EVP & Pres., Life Sciences at AFFYMETRIX INC
- Sold, on record
- $76.2M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Mar 4, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- IRTCiRhythm Technologies, Inc.Director
- AFFYMETRIX INCEVP & Pres., Life Sciences
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- IRTC864,106 shares
- AFFYMETRIX INC12,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale IRTCPlan not statedJan 14 2020
Sold 39,791 shares at $80.00 ($3.2M)
King Kevin M, President and CEO
Sold 15.5% of holdings ($20.5M position)216,660 shares left0.7x usual sizeFiling
- 2 Form 4 sale IRTCPlan not statedJan 15 +1 day
Sold 32,209 shares at $80.00 ($2.6M)
King Kevin M, President and CEO
Sold 12.9% of holdings ($19.9M position)217,141 shares left0.5x usual sizeFiling
- 3 Form 4 sale IRTCPlan not statedMar 13 +58 days
Sold 18,996 shares at $80.19 ($1.5M)
King Kevin M, President and CEO
Sold 7.6% of holdings ($19.9M position)229,512 shares left0.4x usual sizeFiling
- 4 Form 4 sale IRTCPlan not statedMar 24 +11 days
Sold 53,004 shares at $80.00 ($4.2M)
King Kevin M, President and CEO
Sold 18.8% of holdings ($22.6M position)229,512 shares left1.2x usual sizeFiling
- 5 Form 4 sale IRTCPlan not statedMay 19 +56 days
Sold 72,000 shares at $125.62 ($9M)
King Kevin M, President and CEO
Sold 23.9% of holdings ($37.9M position)229,512 shares left1.7x usual sizeFiling
- 6 Form 4 sale IRTCPlan not statedAug 12 +85 days
Sold 59,622 shares at $180.10 ($10.7M)
King Kevin M, President and CEO
Sold 20.6% of holdings ($52.1M position)229,770 shares left1.4x usual sizeFiling
- 7 Form 4 sale IRTCPlan not statedNov 12 +92 days
Sold 31,669 shares at $255.22 ($8.1M)
King Kevin M, President and CEO
Sold 11.6% of holdings ($69.9M position)242,101 shares left0.7x usual sizeFiling
- 8 Form 4 sale IRTCPlan not statedMar 4 +477 days
Sold 6,815 shares at $132.67 ($904k)
King Kevin M, Director
Sold 2.6% of holdings ($34.1M position)250,422 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | IRTC | Director | Form 4 sale | 6,815 | $904k | 2.6% | Plan not stated | SEC |
| Nov 12, 2020 | IRTC | President and CEO | Form 4 sale | 31,669 | $8.1M | 11.6% | Plan not stated | SEC |
| Aug 12, 2020 | IRTC | President and CEO | Form 4 sale | 59,622 | $10.7M | 20.6% | Plan not stated | SEC |
| May 19, 2020 | IRTC | President and CEO | Form 4 sale | 72,000 | $9M | 23.9% | Plan not stated | SEC |
| Mar 24, 2020 | IRTC | President and CEO | Form 4 sale | 53,004 | $4.2M | 18.8% | Plan not stated | SEC |
| Mar 13, 2020 | IRTC | President and CEO | Form 4 sale | 18,996 | $1.5M | 7.6% | Plan not stated | SEC |
| Jan 15, 2020 | IRTC | President and CEO | Form 4 sale | 32,209 | $2.6M | 12.9% | Plan not stated | SEC |
| Jan 14, 2020 | IRTC | President and CEO | Form 4 sale | 39,791 | $3.2M | 15.5% | Plan not stated | SEC |
| May 22, 2019 | IRTC | President and CEO | Form 4 sale | 60,000 | $4.2M | 26.7% | Unusual | SEC |
| Mar 15, 2019 | IRTC | President and CEO | Form 4 sale | 60,000 | $5.3M | 21.1% | Plan not stated | SEC |
| Nov 15, 2018 | IRTC | President and CEO | Form 4 sale | 17,168 | $1.2M | 7.2% | Plan not stated | SEC |
| Nov 13, 2018 | IRTC | President and CEO | Form 4 sale | 42,832 | $3M | 16.2% | Plan not stated | SEC |
| Aug 6, 2018 | IRTC | President and CEO | Form 4 sale | 60,000 | $5M | 21.2% | Plan not stated | SEC |
| May 8, 2018 | IRTC | President and CEO | Form 4 sale | 80,000 | $5.3M | 33.1% | Unusual | SEC |
| Feb 26, 2018 | IRTC | President and CEO | Form 4 sale | 60,000 | $3.9M | 29.7% | Unusual | SEC |
| Nov 6, 2017 | IRTC | President and CEO | Form 4 sale | 60,000 | $3.1M | 58.2% | Unusual | SEC |
| Jul 11, 2017 | IRTC | President and CEO | Form 4 sale | 110,000 | $4.6M | 71.9% | Unusual | SEC |
| Aug 8, 2007 | AFFYMETRIX INC | EVP & Pres., Life Sciences | Form 4 sale | 12,000 | $328k | 17.3% | Plan not stated | SEC |